GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents
作者： Helen K. Reddel , J. Mark FitzGerald , Eric D. Bateman , Leonard B. Bacharier , Allan Becker
DOI: 10.1183/13993003.01046-2019
关键词: Pediatrics 、 Mild asthma 、 Asthma management 、 Asthma 、 Disease management (health) 、 Medicine 、 Inhaler 、 Inhalation 、 Fundamental change 、 Budesonide/formoterol
摘要: GINA no longer recommends treating adults/adolescents with asthma short-acting bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a daily corticosteroid-containing inhaler, to reduce risk of severe exacerbations.http://bit.ly/310LLzE
imperial.ac.uk 
sci-hub.se 参考文章(34)
Louis-Philippe Boulet, Daniel Vervloet, Yves Magar, Juliet M. Foster, Adherence Clinics in Chest Medicine. ,vol. 33, pp. 405- 417 ,(2012) , 10.1016/J.CCM.2012.06.002
PAUL M. O'BYRNE, PETER J. BARNES, ROBERTO RODRIGUEZ-ROISIN, EVA RUNNERSTROM, THOMAS SANDSTROM, KLAS SVENSSON, ANNE TATTERSFIELD, Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. American Journal of Respiratory and Critical Care Medicine. ,vol. 164, pp. 1392- 1397 ,(2001) , 10.1164/AJRCCM.164.8.2104102
Christopher J Cates, Toby J Lasserson, Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children Cochrane Database of Systematic Reviews. ,(2009) , 10.1002/14651858.CD007313.PUB2
D. Dusser, D. Montani, P. Chanez, J. de Blic, C. Delacourt, A. Deschildre, P. Devillier, A. Didier, C. Leroyer, C. Marguet, Y. Martinat, J. Piquet, C. Raherison, P. Serrier, I. Tillie-Leblond, A.-B. Tonnel, M. T. de Lara, M. Humbert, Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations Allergy. ,vol. 62, pp. 591- 604 ,(2007) , 10.1111/J.1398-9995.2007.01394.X
D. Robin Taylor, Malcolm R. Sears, Donald W. Cockcroft, THE BETA-AGONIST CONTROVERSY Medical Clinics of North America. ,vol. 80, pp. 719- 748 ,(1996) , 10.1016/S0025-7125(05)70465-X
Graham Crompton, A brief history of inhaled asthma therapy over the last fifty years. Primary Care Respiratory Journal. ,vol. 15, pp. 326- 331 ,(2006) , 10.1016/J.PCRJ.2006.09.002
Samy Suissa, Pierre Ernst, Serge Benayoun, Marc Baltzan, Bing Cai, Low-dose inhaled corticosteroids and the prevention of death from asthma. The New England Journal of Medicine. ,vol. 343, pp. 332- 336 ,(2000) , 10.1056/NEJM200008033430504
Rob Horne, Compliance, Adherence, and Concordance Chest. ,vol. 130, pp. 65S- 72S ,(2006) , 10.1378/CHEST.130.1_SUPPL.65S
Robert J. Hancox, Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis. Clinical Reviews in Allergy & Immunology. ,vol. 31, pp. 279- 288 ,(2006) , 10.1385/CRIAI:31:2:279
S Suissa, P Ernst, J F Boivin, R I Horwitz, B Habbick, D Cockroft, L Blais, M McNutt, A S Buist, W O Spitzer, A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. American Journal of Respiratory and Critical Care Medicine. ,vol. 149, pp. 604- 610 ,(1994) , 10.1164/AJRCCM.149.3.8118625